Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer
Katherine D Crew1, Marilie D Gammon, Mary Beth Terry
1Department of Epidemiology, Mailman School of Public Health, Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA. kd59@columbia.edu
Abstract:
Genes involved in the nucleotide excision repair (NER) pathway, which removes bulky DNA adducts, are potential low-penetrance cancer susceptibility genes. We recently reported an association between detectable polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer risk. Using a population-based breast cancer case-control study on Long Island, New York, we examined whether polymorphisms in NER genes modified the association between PAH-DNA adducts and breast cancer risk. We examined polymorphisms in ERCC1 (3'-untranslated region 8092C/A), XPA (5'-untranslated region -4G/A), XPD (Asp(312)Asn in exon 10), XPF (Arg(415)Gln in exon 8), and XPG (Asp(1104)His in exon 15) in 1,053 breast cancer cases and 1,102 population-based controls. The presence of at least one variant allele in XPD was associated with a 25% increase in the odds ratio [OR, 1.25; 95% confidence interval (95% CI), 1.04-1.50] for breast cancer. The increase associated with homozygosity of the variant alleles for XPD and ERCC1 was stronger among those with detectable PAH-DNA adduct levels (OR, 1.83; 95% CI, 1.22-2.76 and OR, 1.92; 95% CI, 1.14-3.25 for detectable versus nondetectable adducts and homozygous wild-type genotype for XPD and ERCC1, respectively). We found no association between XPA, XPF, and XPG genotypes, PAH-DNA adducts, and breast cancer risk. When we combined genotypes for these NER pathway genes, there was a significant trend for increasing breast cancer risk with increasing number of putative high-risk alleles. Overall, this study suggests that the risk of breast cancer may be elevated among women with polymorphisms in NER pathway genes and detectable PAH-DNA adducts.
Insights
Genetic variations in nucleotide excision repair (NER) genes may increase breast cancer risk, especially when combined with polycyclic aromatic hydrocarbon (PAH)-DNA adducts. This suggests a gene-environment interaction influencing cancer susceptibility.
Area of Science:
- Genetics
- Environmental Health
- Cancer Epidemiology
Background:
- Nucleotide excision repair (NER) pathway genes are implicated in removing DNA damage, acting as potential low-penetrance cancer susceptibility genes.
- Previous research indicated a link between polycyclic aromatic hydrocarbon (PAH)-DNA adducts and increased breast cancer risk.
- The role of genetic polymorphisms within NER genes in modifying this association remains to be fully elucidated.
Purpose of the Study:
- To investigate whether polymorphisms in key NER genes (ERCC1, XPA, XPD, XPF, XPG) modify the association between PAH-DNA adducts and breast cancer risk.
- To assess the combined effect of multiple NER gene polymorphisms on breast cancer risk in the context of PAH-DNA adduct exposure.
Main Methods:
- A population-based breast cancer case-control study was conducted on Long Island, New York, involving 1,053 cases and 1,102 controls.
- Genotyping was performed for polymorphisms in ERCC1, XPA, XPD, XPF, and XPG.
- PAH-DNA adduct levels were measured, and their association with breast cancer risk was analyzed in relation to NER gene genotypes.
Main Results:
- Carriage of at least one variant allele in the XPD gene was associated with a 25% increased odds of breast cancer.
- The risk increase associated with homozygous variant genotypes in XPD and ERCC1 was significantly amplified in individuals with detectable PAH-DNA adducts.
- No significant associations were observed for XPA, XPF, and XPG genotypes with breast cancer risk or PAH-DNA adduct levels. A trend of increasing breast cancer risk was observed with a higher number of high-risk NER alleles.
Conclusions:
- Polymorphisms in NER pathway genes, particularly XPD and ERCC1, may elevate breast cancer risk, especially in the presence of detectable PAH-DNA adducts.
- These findings suggest a gene-environment interaction where NER gene variations modify susceptibility to breast cancer induced by PAH exposure.
- Further research into NER pathway gene polymorphisms could enhance our understanding of breast cancer etiology and identify high-risk individuals.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Base Excision Repair
The first step of...
Base Excision Repair
The first step of...
Long-patch Base Excision Repair

